Synopsis: CAPLYTA is the only FDA-approved treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults as…
Tag:
Schizophrenia
-
-
Agrochemicals
Janssen Pharma’s Byannli (PP6M) receives European approval for Maintenance Treatment of Schizophrenia in Adults.
by adminby adminKEYPOINTS: Janssen has won approval from the European Commission for Byannli, a six-month formulation of Paliperidone Palmitate, two months after receiving a…